Press Releases

and/or
561 News Releases found
Memorial Sloan Kettering Announces New Appointments

Memorial Sloan Kettering Cancer Center announces the appointments of medical oncologist Anas Younes, surgical pathologist David S. Kimstra, surgeon Julio Garcia-Aguilar, and radiologist Wolfgang Weber.
Drug Shown to Reverse Radioiodine Resistance in Some Advanced Thyroid Cancers

The experimental drug selumetinib may allow some patients with advanced thyroid cancer to overcome resistance to radioiodine (RAI), the most effective therapy for the disease, according to new research from Memorial Sloan Kettering Cancer Center.
Westchester Medical Center Opens New Outpatient Oncology Center in Partnership with Memorial Sloan Kettering

Westchester Medical Center today announced the opening of its new 5,300-square-foot outpatient Infusion Center, ushering in a new partnership with Memorial Sloan Kettering Cancer Center, whose staff will provide outpatient cancer care and infusion services.
IBM Watson Hard At Work: New Breakthroughs Transform Quality Care for Patients

IBM, WellPoint, Inc., and Memorial Sloan Kettering Cancer Center today unveiled the first commercially developed Watson-based cognitive computing breakthroughs. These innovations stand alone to help transform the quality and speed of care delivered to patients through individualized, evidence-based medicine.
Pictured: Paul Sabbatini
New Position Created to Streamline, Accelerate, and Expand Clinical Research at Memorial Sloan Kettering

Memorial Sloan Kettering Cancer Center has announced the appointment of medical oncologist Paul Sabbatini to the new position of Deputy Physician-in-Chief for Clinical Research.
David M. Rubenstein Gives $10 Million to Launch Pancreatic Cancer Research Center at Memorial Sloan Kettering

A new pancreatic cancer research center has been created at Memorial Sloan Kettering Cancer Center (MSKCC). The ambitious initiative was established with an initial commitment of $10 million from MSKCC Board member David M. Rubenstein.
Media Advisory
Medication Before and After Treatment Improves Overall Sexual Function in Men with Prostate Cancer

Prostate cancer patients who are prescribed oral erectile medication before and after radiation therapy have improved sexual function, according to a research team at Memorial Sloan Kettering Cancer Center.
Pictured: José Baselga
Memorial Sloan Kettering Cancer Center Announces Appointment of New Physician-in-Chief

Internationally recognized physician-scientist José Baselga has been named Physician-in-Chief of Memorial Hospital. He joins Memorial Sloan Kettering from Massachusetts General Hospital.
Childhood Cancer Treatment Found to Pose Similar Risk for Breast Cancer as BRCA Mutations

New data reveals that women treated with radiation to the chest for childhood cancer have a high risk of developing breast cancer similar to that of women with <i>BRCA1/2</i> mutations. The study, led by Memorial Sloan Kettering Cancer Center biostatistician Chaya Moskowitz, PhD, was presented today at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.
Testing for Mutations Identified in Squamous Cell Lung Cancer Tumors Helps Personalize Treatment

Researchers from Memorial Sloan Kettering Cancer Center have begun testing for three new genetic targets and found that together they occur in approximately 50 percent of patients with squamous cell carcinomas of the lung, which affects 40,000 Americans each year. Initial findings of the research will be presented on June 4 at the 2012 American Society of Clinical Oncology (ASCO) Annual Meeting.